soul semaglutide oral cardiovascular benefit study in High-Risk Type 2 Diabetes: Confirmed in the Trial Trial Scorecard: SOUL – Oral Semaglutide in High-Risk Type – Expanding cardiovascular indications for semaglutide:

Reasons for shortages: Very high demand for weight loss treatment Limited production Priority given to diabetes patients first Countries reporting shortages in 2025: United Kingdom Germany France Spain Italy Denmark Sweden To help manage this: Plan your prescription refills ahead of time Be flexible about the brand or dose if needed Be aware that temporary supply issues may occur

More recent evidence suggests myeloid cells in the CNS are also important for controlling the chronic infection, although the precise role of these cells in immune defense is not well understood

Bloating hangs around longer than usual, foods feel harder to tolerate, and your stomach just doesnt feel settled

It is the salt of benzoic acid